"Determination prostate specific antigen and testosterone in tumour cell lines with encore zinc and sarcosine as well as in prostate cancer patients"@en . "Kizek, Ren\u00E9" . "[243C54863465]" . . . "Sochor, Ji\u0159\u00ED" . "Gumulec, Jarom\u00EDr" . "6"^^ . "2011-01-01+01:00"^^ . . . . . . "RIV/62156489:43210/11:00173831!RIV12-AV0-43210___" . "Determination prostate specific antigen and testosterone in tumour cell lines with encore zinc and sarcosine as well as in prostate cancer patients" . . "Cernei, Natalia Vladimirovna" . "Brno" . "5"^^ . . . . "7"^^ . "Determination prostate specific antigen and testosterone in tumour cell lines with encore zinc and sarcosine as well as in prostate cancer patients"@en . . "tumor cells; specific antigen; prostate cancer"@en . "193928" . "Mendelova zem\u011Bd\u011Blsk\u00E1 a lesnick\u00E1 univerzita v Brn\u011B" . . . . "Babula, Petr" . . . "MENDELU" . "Masa\u0159\u00EDk, Michal" . "RIV/62156489:43210/11:00173831" . "XI. pracovn\u00ED setk\u00E1n\u00ED fyzik\u00E1ln\u00EDch chemik\u016F a elektrochemik\u016F" . . . "Tumour markers are biochemical indicators of malignant tumour proliferation. They serve not only for diagnostics of malignant tumour diseases, but also for monitoring of effect of therapy and recurrence of disease. One of the most important indicators of quality of oncological markers is their sensitivity; it means the possibility to detect diseases at the early stages, and specificity to given type of tumour. In the case of prostate carcinoma, prostatic acid phosphatase (PAP) was usually used in the past. PAP was replaced at the end of eighties of last century by serum prostate specific antigen (PSA), which belongs to a group of the best tumour markers, currently available."@en . . "P(GP301/09/P436), P(KAN208130801)" . . "Tumour markers are biochemical indicators of malignant tumour proliferation. They serve not only for diagnostics of malignant tumour diseases, but also for monitoring of effect of therapy and recurrence of disease. One of the most important indicators of quality of oncological markers is their sensitivity; it means the possibility to detect diseases at the early stages, and specificity to given type of tumour. In the case of prostate carcinoma, prostatic acid phosphatase (PAP) was usually used in the past. PAP was replaced at the end of eighties of last century by serum prostate specific antigen (PSA), which belongs to a group of the best tumour markers, currently available." . . "978-80-7375-514-0" . "Z\u00EDtka, Ond\u0159ej" . "Determination prostate specific antigen and testosterone in tumour cell lines with encore zinc and sarcosine as well as in prostate cancer patients" . "43210" .